REQUEST A DEMO
Total
USD $0.00
Search more companies

Respimedic Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Respimedic Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Respimedic Sdn. Bhd. is based in Malaysia. The head office is in Puchong. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on April 03, 2002. The company’s latest financial report indicates a net sales revenue drop of 63.83% in 2023. There was a total growth of 0.45% in Respimedic Sdn. Bhd.’s total assets over the same period. The net profit margin of Respimedic Sdn. Bhd. decreased by 5.77% in 2023.

Headquarters
36 Jalan Bpu 6, Bandar Puchong Utama,
Puchong; Selangor; Postal Code: 47100

Contact Details: Purchase the Respimedic Sdn. Bhd. report to view the information.

Website: http://www.respimedic.com

Basic Information
Outstanding Shares:
Purchase the Respimedic Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Respimedic Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Respimedic Sdn. Bhd. report to view the information.
Incorporation Date:
April 03, 2002
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Med Alpha Marketing Sdn. Bhd.
33.33%
Company Performance
Financial values in the chart are available after Respimedic Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-63.83%
Total operating revenue
-63.83%
Operating profit (EBIT)
-84.43%
Net Profit (Loss) for the Period
-87.06%
Total assets
0.45%
Total equity
1.81%
Operating Profit Margin (ROS)
-6.42%
Net Profit Margin
-5.77%
Return on Equity (ROE)
-12.23%
Quick Ratio
3.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?